U.S. pharma large copyright scrapped two experimental weight loss supplements last 12 months—a when-day by day tablet, lotiglipron, because of elevated liver enzymes and also a 2 times-every day tablet, danuglipron, as a result of potent Unwanted side effects—but CEO Albert Bourla ha